USPTO serial 76706972
D-PAC
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PINO, BRIAN
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with D-PAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Jose, CA
San Jose, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William L Paradice III
William L Paradice III Mahamedi Paradice Kreisman LLP550 S. Winchester Boulevard,Ste. 605San Jose, CA 95128Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological, chemical, therapeutic and diagnostic preparations for medical or surgical purposes for use in the treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders, namely, transdermal patches containing medication, iontophoretic and dermatological preparations, reagents and pharmaceuticals, and kits consisting of two or more of the aforementioned goods; pharmaceutical preparations for use in treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; drug delivery agents in the form of capsule, coating, tablet, or powder containing compounds that facilitate delivery and release of a wide range of pharmaceuticals and therapeutic agents; pharmaceuticals for use in treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; therapeutic preparations for use in treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders | ACTIVE | — |
| 010 | Therapeutic apparatus, namely, transdermal, iontophoretic and dermatological apparatus, for diagnosing, treating, preventing and improving disease, disorder or condition and for use in the treatment of micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; medical devices for the purposes of treating micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; medical and surgical implants consisting of artificial materials for the purposes of treating micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; drug delivery systems for the purposes of treating micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders; medical instruments for the purposes of treating micronutrient deficiency, anemia, and central nervous system, cardiovascular, metabolic, gastrointestinal, renal and oncological diseases, conditions and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 3, 2013 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 3, 2013 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 30, 2012 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 4, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 4, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 30, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 27, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 26, 2012 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 26, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2012 | PAPER RECEIVED | — | |
| Jul 11, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 11, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 13, 2012 | DMCC | DATA MODIFICATION COMPLETED | — |
| Jan 12, 2012 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 12, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 22, 2011 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Dec 22, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 15, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 13, 2011 | PAPER RECEIVED | — | |
| Jun 8, 2011 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 1, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 5, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 30, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |